These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 5381888

  • 21. [Kanamycin and florimycin in the clinical course of pulmonary tuberculosis].
    Bialik IB.
    Antibiotiki; 1971 Feb; 16(2):184-8. PubMed ID: 4326728
    [No Abstract] [Full Text] [Related]

  • 22. Experience with cycloserine.
    Dissmann E.
    Scand J Respir Dis Suppl; 1970 Feb; 71():239-43. PubMed ID: 5317744
    [No Abstract] [Full Text] [Related]

  • 23. [Results of treatment of chronic destructive pulmonary tuberculosis with reserve tuberculostatic preparations including some new preparations].
    Rabukhin AE, Alekseeva VM, Ivanova ES, Kubyshkina VF, Kliuchareva EA.
    Probl Tuberk; 1970 Feb; 48(8):18-22. PubMed ID: 5496733
    [No Abstract] [Full Text] [Related]

  • 24. [The results of treatment with minor drugs, i.e. kanamycin, ethionamide and cycloserine, for severe pulmonary tuberculosis patients discharging bacilli resistant to all the three major drugs].
    Matsumoto M, Izumi K, Kamima H, Hirose H, Saito M.
    Kekkaku; 1966 Jan; 41(1):39-46. PubMed ID: 5962711
    [No Abstract] [Full Text] [Related]

  • 25. [Resistance of tubercle bacilli to cycloserine, viomycin and ethionamide in patients suffering from pulmonary tuberculosis].
    Srednicka-Zajac D, Mysakowska H, Szarewicz-Adamczyk W, Litwin B.
    Ann Univ Mariae Curie Sklodowska Med; 1967 Jan; 22():71-8. PubMed ID: 4308440
    [No Abstract] [Full Text] [Related]

  • 26. [Tuberculostatic preparations of the 2d series in the clinical treatment of pulmonary tuberculosis].
    Kaminskaia AA, Utkin VV, Korotaev GA, Golitsina LV.
    Probl Tuberk; 1967 Jan; 45(5):29-33. PubMed ID: 5617941
    [No Abstract] [Full Text] [Related]

  • 27. [A scheme of triple reserve drugs in the treatment of resistant forms of pulmonary tuberculosis].
    Rizzo A, Magalhães M, Moura N.
    Hospital (Rio J); 1966 Sep; 70(3):767-83. PubMed ID: 5300283
    [No Abstract] [Full Text] [Related]

  • 28. [Results of treatment of pulmonary tuberculosis in adults with second line drugs].
    Ropek M, Szymański A, Chetkowski A, Tarocińska B.
    Gruzlica; 1968 Oct; 36(10):1043-6. PubMed ID: 5710086
    [No Abstract] [Full Text] [Related]

  • 29. A comparison of ethionamide-cycloserine and ethionamide-pyrazinamide regimens in patients resistant to major chemotherapeutics.
    Vidinel I.
    Scand J Respir Dis Suppl; 1970 Oct; 71():192-5. PubMed ID: 5271985
    [No Abstract] [Full Text] [Related]

  • 30. [Current questions in the treatment of patients with chronic destructive pulmonary tuberculosis].
    Mamolat AS, Bialik IB, Khutorskaia VD.
    Klin Med (Mosk); 1976 Dec; 54(12):72-8. PubMed ID: 189127
    [No Abstract] [Full Text] [Related]

  • 31. [Observations on antituberculous drug-resistance among pulmonary tuberculosis patients at the National Sanatoria in Kyushu district. 3. The secondary anti-tuberculosis agents (kanamycin, cycloserine, ethionamide)].
    Yamaguchi S.
    Iryo; 1968 Oct; 22(10):1115-9. PubMed ID: 5715475
    [No Abstract] [Full Text] [Related]

  • 32. Results after retreatment of advanced pulmonary tuberculosis with rifampin and other drugs.
    Pines A.
    Am Rev Respir Dis; 1971 Jul; 104(1):126-7. PubMed ID: 4104090
    [No Abstract] [Full Text] [Related]

  • 33. [Therapeutic effects of secondary antitubercular agents at our hospital].
    Nakayama K, Hayashida M, Ishihara M, Ijichi F, Obata Y.
    Iryo; 1966 Mar; 20(3):257-63. PubMed ID: 5964832
    [No Abstract] [Full Text] [Related]

  • 34. [Combination of ethambutol with ethionamide, cycloserine and-or pyrazynamide in retreatment of pulmonary tuberculosis].
    Kekkaku; 1968 Feb; 43(2):91-5. PubMed ID: 5678013
    [No Abstract] [Full Text] [Related]

  • 35. [Treatment of chronic destructive forms of pulmonary tuberculosis with drugs of the second series in different combinations].
    Mamolat AS, Bialik IB.
    Probl Tuberk; 1969 Feb; 47(6):23-8. PubMed ID: 4311969
    [No Abstract] [Full Text] [Related]

  • 36. [Results of 2 or 3 secondary drug combinations in the retreatment of chronic pulmonary tuberculosis].
    De March Ayuela P, Turell Gumá J.
    Rev Clin Esp; 1968 Apr 30; 109(2):117-26. PubMed ID: 4904020
    [No Abstract] [Full Text] [Related]

  • 37. [Late results of treatment of chronic, cavernous pulmonary tuberculosis with reserve drugs].
    Zierski M, Zachara A.
    Gruzlica; 1968 Apr 30; 37(1):31-8. PubMed ID: 5720035
    [No Abstract] [Full Text] [Related]

  • 38. [Use of drugs of secondary group in complex therapy of children with chronic tuberculosis].
    Rushchak VA.
    Pediatr Akus Ginekol; 1971 Apr 30; 2():24-5. PubMed ID: 4254375
    [No Abstract] [Full Text] [Related]

  • 39. [Restoration of drug sensitivity in Mycobacterium tuberculosis to streptomycin and isoniazid during treatment with preparations of the 1st series].
    Rudoĭ NM, Utkin VV, Fedorova IE, Afanas'eva IuP.
    Antibiotiki; 1970 Apr 30; 15(4):355-7. PubMed ID: 4993044
    [No Abstract] [Full Text] [Related]

  • 40. [Possibilities and limitations of multiple chemoantibiotics in treatment of chronic pulmonary tuberculosis].
    Zanotelli F, Perusi O.
    G Ital Mal Torace; 1966 Apr 30; 20(6):365-78. PubMed ID: 5997781
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.